Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (481)

Latest Posts

About This Stock More About This Stock
Next Week Trading Opportunities - GILD, ETSY, FCEL, PLUG, SNOW, AAPL
Article By: Tickeron
Sunday, November 21, 2021 11:40 AM EST
With the assistance of AI we can identify patterns, trends, and buy/sell signals. Here are the prospects in the coming week for these six stocks.
In this article: FCEL, PLUG, AAPL, GILD, ETSY, SNOW
Read
This Cheap Stock Is Paying An Unusually High Yield
Video By: Jason Fieber
Monday, November 1, 2021 4:00 PM EST
Gilead has increased their dividend for seven consecutive years. The three-year dividend growth rate of 9.4% shows the level of growth they’re capable of delivering.
In this video: GILD
Watch
Gilead Sciences (GILD) Q3 Earnings And Revenues Surpass Estimates
Article By: Zacks Investment Research
Thursday, October 28, 2021 6:53 PM EST
Gilead Sciences came out with quarterly earnings of $2.65 per share.
In this article: GILD
Read
GILD: Is This Biotech’s 4.2% Yield Healthy?
Article By: Marc Lichtenfeld
Wednesday, October 27, 2021 7:13 PM EST
Gilead’s free cash flow hit a recent peak of $19.5 billion in 2015 before falling each of the next two years, settling around $7.5 billion in 2018.
In this article: GILD
Read
2 Biotech Stocks That Are Dirt Cheap Right Now
Article By: StockNews
Tuesday, July 13, 2021 8:06 AM EST
Biotech companies responded to the COVID-19 pandemic in a remarkable way, with vaccinations, treatments, diagnostics, and variant monitoring.
In this article: REGN, GILD
Read

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments